aluates Reports

$ 0.0

Automative

Global Osteoarthritis Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-21R17181

Global Osteoarthritis Therapeutics Market Research Report 2024

BUY CHAPTERS

Global Osteoarthritis Therapeutics Market Research Report 2025

Code: QYRE-Auto-21R17181

Report

September 2025

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Johnson & Johnson

GlaxoSmithKline PLC

Bayer

Eli Lilly

Novartis

Sanofi

Horizon Pharma

Abbott

Mylan NV

Daiichi Sankyo

TEVA

Almatica Pharma

Astellas Pharma

Tide Pharmaceutical

Iroko Pharmaceuticals

Hengrui Pharmaceutical

Abiogen Pharma

Johnson & Johnson

Osteoarthritis Therapeutics Market Size

The global market for Osteoarthritis Therapeutics was valued at US$ 6488 million in the year 2024 and is projected to reach a revised size of US$ 8849 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Osteoarthritis Therapeutics Market

This report studies Osteoarthritis Therapeutics market, the main role of Osteoarthritis Therapeutics is to relieve pain, and cannot slow the progress of osteoarthritis.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Osteoarthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteoarthritis Therapeutics.

The Osteoarthritis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Osteoarthritis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Osteoarthritis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Osteoarthritis Therapeutics Market Report

Report Metric	Details
Report Name	Osteoarthritis Therapeutics Market
Accounted market size in year	US$ 6488 million
Forecasted market size in 2031	US$ 8849 million
CAGR	4.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Oral Injection External
Segment by Application	Medical Care Personal Care
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Osteoarthritis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Osteoarthritis Therapeutics Market growing?

Ans: The Osteoarthritis Therapeutics Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Osteoarthritis Therapeutics Market size in 2031?

Ans: The Osteoarthritis Therapeutics Market size in 2031 will be US$ 8849 million.

Who are the main players in the Osteoarthritis Therapeutics Market report?

Ans: The main players in the Osteoarthritis Therapeutics Market are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma

What are the Application segmentation covered in the Osteoarthritis Therapeutics Market report?

Ans: The Applications covered in the Osteoarthritis Therapeutics Market report are Medical Care, Personal Care

What are the Type segmentation covered in the Osteoarthritis Therapeutics Market report?

Ans: The Types covered in the Osteoarthritis Therapeutics Market report are Oral, Injection, External

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Osteoarthritis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oral

1.2.3 Injection

1.2.4 External

1.3 Market by Application

1.3.1 Global Osteoarthritis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Medical Care

1.3.3 Personal Care

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Osteoarthritis Therapeutics Market Perspective (2020-2031)

2.2 Global Osteoarthritis Therapeutics Growth Trends by Region

2.2.1 Global Osteoarthritis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Osteoarthritis Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Osteoarthritis Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Osteoarthritis Therapeutics Market Dynamics

2.3.1 Osteoarthritis Therapeutics Industry Trends

2.3.2 Osteoarthritis Therapeutics Market Drivers

2.3.3 Osteoarthritis Therapeutics Market Challenges

2.3.4 Osteoarthritis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Osteoarthritis Therapeutics Players by Revenue

3.1.1 Global Top Osteoarthritis Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Osteoarthritis Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Osteoarthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Osteoarthritis Therapeutics Revenue

3.4 Global Osteoarthritis Therapeutics Market Concentration Ratio

3.4.1 Global Osteoarthritis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Osteoarthritis Therapeutics Revenue in 2024

3.5 Global Key Players of Osteoarthritis Therapeutics Head office and Area Served

3.6 Global Key Players of Osteoarthritis Therapeutics, Product and Application

3.7 Global Key Players of Osteoarthritis Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Osteoarthritis Therapeutics Breakdown Data by Type

4.1 Global Osteoarthritis Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Osteoarthritis Therapeutics Forecasted Market Size by Type (2026-2031)

5 Osteoarthritis Therapeutics Breakdown Data by Application

5.1 Global Osteoarthritis Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Osteoarthritis Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Osteoarthritis Therapeutics Market Size (2020-2031)

6.2 North America Osteoarthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Osteoarthritis Therapeutics Market Size by Country (2020-2025)

6.4 North America Osteoarthritis Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Osteoarthritis Therapeutics Market Size (2020-2031)

7.2 Europe Osteoarthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Osteoarthritis Therapeutics Market Size by Country (2020-2025)

7.4 Europe Osteoarthritis Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Osteoarthritis Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Osteoarthritis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Osteoarthritis Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Osteoarthritis Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Osteoarthritis Therapeutics Market Size (2020-2031)

9.2 Latin America Osteoarthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Osteoarthritis Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Osteoarthritis Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Osteoarthritis Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Osteoarthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Osteoarthritis Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Osteoarthritis Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Osteoarthritis Therapeutics Introduction

11.1.4 Pfizer Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Osteoarthritis Therapeutics Introduction

11.2.4 Johnson & Johnson Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.2.5 Johnson & Johnson Recent Development

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Details

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Osteoarthritis Therapeutics Introduction

11.3.4 GlaxoSmithKline Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.3.5 GlaxoSmithKline Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Osteoarthritis Therapeutics Introduction

11.4.4 Bayer Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.4.5 Bayer Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Osteoarthritis Therapeutics Introduction

11.5.4 Eli Lilly Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.5.5 Eli Lilly Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Osteoarthritis Therapeutics Introduction

11.6.4 Novartis Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.6.5 Novartis Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Osteoarthritis Therapeutics Introduction

11.7.4 Sanofi Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.7.5 Sanofi Recent Development

11.8 Horizon Pharma

11.8.1 Horizon Pharma Company Details

11.8.2 Horizon Pharma Business Overview

11.8.3 Horizon Pharma Osteoarthritis Therapeutics Introduction

11.8.4 Horizon Pharma Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.8.5 Horizon Pharma Recent Development

11.9 Abbott

11.9.1 Abbott Company Details

11.9.2 Abbott Business Overview

11.9.3 Abbott Osteoarthritis Therapeutics Introduction

11.9.4 Abbott Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.9.5 Abbott Recent Development

11.10 Mylan

11.10.1 Mylan Company Details

11.10.2 Mylan Business Overview

11.10.3 Mylan Osteoarthritis Therapeutics Introduction

11.10.4 Mylan Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.10.5 Mylan Recent Development

11.11 Daiichi Sankyo

11.11.1 Daiichi Sankyo Company Details

11.11.2 Daiichi Sankyo Business Overview

11.11.3 Daiichi Sankyo Osteoarthritis Therapeutics Introduction

11.11.4 Daiichi Sankyo Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.11.5 Daiichi Sankyo Recent Development

11.12 TEVA

11.12.1 TEVA Company Details

11.12.2 TEVA Business Overview

11.12.3 TEVA Osteoarthritis Therapeutics Introduction

11.12.4 TEVA Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.12.5 TEVA Recent Development

11.13 Almatica Pharma

11.13.1 Almatica Pharma Company Details

11.13.2 Almatica Pharma Business Overview

11.13.3 Almatica Pharma Osteoarthritis Therapeutics Introduction

11.13.4 Almatica Pharma Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.13.5 Almatica Pharma Recent Development

11.14 Astellas Pharma

11.14.1 Astellas Pharma Company Details

11.14.2 Astellas Pharma Business Overview

11.14.3 Astellas Pharma Osteoarthritis Therapeutics Introduction

11.14.4 Astellas Pharma Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.14.5 Astellas Pharma Recent Development

11.15 Tide Pharmaceutical

11.15.1 Tide Pharmaceutical Company Details

11.15.2 Tide Pharmaceutical Business Overview

11.15.3 Tide Pharmaceutical Osteoarthritis Therapeutics Introduction

11.15.4 Tide Pharmaceutical Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.15.5 Tide Pharmaceutical Recent Development

11.16 Iroko Pharmaceuticals

11.16.1 Iroko Pharmaceuticals Company Details

11.16.2 Iroko Pharmaceuticals Business Overview

11.16.3 Iroko Pharmaceuticals Osteoarthritis Therapeutics Introduction

11.16.4 Iroko Pharmaceuticals Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.16.5 Iroko Pharmaceuticals Recent Development

11.17 Hengrui Pharmaceutical

11.17.1 Hengrui Pharmaceutical Company Details

11.17.2 Hengrui Pharmaceutical Business Overview

11.17.3 Hengrui Pharmaceutical Osteoarthritis Therapeutics Introduction

11.17.4 Hengrui Pharmaceutical Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.17.5 Hengrui Pharmaceutical Recent Development

11.18 Abiogen Pharma

11.18.1 Abiogen Pharma Company Details

11.18.2 Abiogen Pharma Business Overview

11.18.3 Abiogen Pharma Osteoarthritis Therapeutics Introduction

11.18.4 Abiogen Pharma Revenue in Osteoarthritis Therapeutics Business (2020-2025)

11.18.5 Abiogen Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Johnson & Johnson

GlaxoSmithKline PLC

Bayer

Eli Lilly

Novartis

Sanofi

Horizon Pharma

Abbott

Mylan NV

Daiichi Sankyo

TEVA

Almatica Pharma

Astellas Pharma

Tide Pharmaceutical

Iroko Pharmaceuticals

Hengrui Pharmaceutical

Abiogen Pharma

Johnson & Johnson

List of Tables

Table 1. Global Osteoarthritis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral

Table 3. Key Players of Injection

Table 4. Key Players of External

Table 5. Global Osteoarthritis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Osteoarthritis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Osteoarthritis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Osteoarthritis Therapeutics Market Share by Region (2020-2025)

Table 9. Global Osteoarthritis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Osteoarthritis Therapeutics Market Share by Region (2026-2031)

Table 11. Osteoarthritis Therapeutics Market Trends

Table 12. Osteoarthritis Therapeutics Market Drivers

Table 13. Osteoarthritis Therapeutics Market Challenges

Table 14. Osteoarthritis Therapeutics Market Restraints

Table 15. Global Osteoarthritis Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Osteoarthritis Therapeutics Market Share by Players (2020-2025)

Table 17. Global Top Osteoarthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Therapeutics as of 2024)

Table 18. Ranking of Global Top Osteoarthritis Therapeutics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Osteoarthritis Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Osteoarthritis Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Osteoarthritis Therapeutics, Product and Application

Table 22. Global Key Players of Osteoarthritis Therapeutics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Osteoarthritis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Osteoarthritis Therapeutics Revenue Market Share by Type (2020-2025)

Table 26. Global Osteoarthritis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Osteoarthritis Therapeutics Revenue Market Share by Type (2026-2031)

Table 28. Global Osteoarthritis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Osteoarthritis Therapeutics Revenue Market Share by Application (2020-2025)

Table 30. Global Osteoarthritis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Osteoarthritis Therapeutics Revenue Market Share by Application (2026-2031)

Table 32. North America Osteoarthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Osteoarthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Osteoarthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Osteoarthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Osteoarthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Osteoarthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Osteoarthritis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Osteoarthritis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Osteoarthritis Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Osteoarthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Osteoarthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Osteoarthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Osteoarthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Osteoarthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Osteoarthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Osteoarthritis Therapeutics Product

Table 50. Pfizer Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Johnson & Johnson Company Details

Table 53. Johnson & Johnson Business Overview

Table 54. Johnson & Johnson Osteoarthritis Therapeutics Product

Table 55. Johnson & Johnson Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 56. Johnson & Johnson Recent Development

Table 57. GlaxoSmithKline Company Details

Table 58. GlaxoSmithKline Business Overview

Table 59. GlaxoSmithKline Osteoarthritis Therapeutics Product

Table 60. GlaxoSmithKline Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 61. GlaxoSmithKline Recent Development

Table 62. Bayer Company Details

Table 63. Bayer Business Overview

Table 64. Bayer Osteoarthritis Therapeutics Product

Table 65. Bayer Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 66. Bayer Recent Development

Table 67. Eli Lilly Company Details

Table 68. Eli Lilly Business Overview

Table 69. Eli Lilly Osteoarthritis Therapeutics Product

Table 70. Eli Lilly Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 71. Eli Lilly Recent Development

Table 72. Novartis Company Details

Table 73. Novartis Business Overview

Table 74. Novartis Osteoarthritis Therapeutics Product

Table 75. Novartis Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 76. Novartis Recent Development

Table 77. Sanofi Company Details

Table 78. Sanofi Business Overview

Table 79. Sanofi Osteoarthritis Therapeutics Product

Table 80. Sanofi Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 81. Sanofi Recent Development

Table 82. Horizon Pharma Company Details

Table 83. Horizon Pharma Business Overview

Table 84. Horizon Pharma Osteoarthritis Therapeutics Product

Table 85. Horizon Pharma Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 86. Horizon Pharma Recent Development

Table 87. Abbott Company Details

Table 88. Abbott Business Overview

Table 89. Abbott Osteoarthritis Therapeutics Product

Table 90. Abbott Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 91. Abbott Recent Development

Table 92. Mylan Company Details

Table 93. Mylan Business Overview

Table 94. Mylan Osteoarthritis Therapeutics Product

Table 95. Mylan Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 96. Mylan Recent Development

Table 97. Daiichi Sankyo Company Details

Table 98. Daiichi Sankyo Business Overview

Table 99. Daiichi Sankyo Osteoarthritis Therapeutics Product

Table 100. Daiichi Sankyo Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 101. Daiichi Sankyo Recent Development

Table 102. TEVA Company Details

Table 103. TEVA Business Overview

Table 104. TEVA Osteoarthritis Therapeutics Product

Table 105. TEVA Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 106. TEVA Recent Development

Table 107. Almatica Pharma Company Details

Table 108. Almatica Pharma Business Overview

Table 109. Almatica Pharma Osteoarthritis Therapeutics Product

Table 110. Almatica Pharma Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 111. Almatica Pharma Recent Development

Table 112. Astellas Pharma Company Details

Table 113. Astellas Pharma Business Overview

Table 114. Astellas Pharma Osteoarthritis Therapeutics Product

Table 115. Astellas Pharma Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 116. Astellas Pharma Recent Development

Table 117. Tide Pharmaceutical Company Details

Table 118. Tide Pharmaceutical Business Overview

Table 119. Tide Pharmaceutical Osteoarthritis Therapeutics Product

Table 120. Tide Pharmaceutical Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 121. Tide Pharmaceutical Recent Development

Table 122. Iroko Pharmaceuticals Company Details

Table 123. Iroko Pharmaceuticals Business Overview

Table 124. Iroko Pharmaceuticals Osteoarthritis Therapeutics Product

Table 125. Iroko Pharmaceuticals Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 126. Iroko Pharmaceuticals Recent Development

Table 127. Hengrui Pharmaceutical Company Details

Table 128. Hengrui Pharmaceutical Business Overview

Table 129. Hengrui Pharmaceutical Osteoarthritis Therapeutics Product

Table 130. Hengrui Pharmaceutical Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 131. Hengrui Pharmaceutical Recent Development

Table 132. Abiogen Pharma Company Details

Table 133. Abiogen Pharma Business Overview

Table 134. Abiogen Pharma Osteoarthritis Therapeutics Product

Table 135. Abiogen Pharma Revenue in Osteoarthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 136. Abiogen Pharma Recent Development

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

Table 140. Authors List of This Report

List of Figures

Figure 1. Osteoarthritis Therapeutics Picture

Figure 2. Global Osteoarthritis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Osteoarthritis Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Oral Features

Figure 5. Injection Features

Figure 6. External Features

Figure 7. Global Osteoarthritis Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Osteoarthritis Therapeutics Market Share by Application: 2024 VS 2031

Figure 9. Medical Care Case Studies

Figure 10. Personal Care Case Studies

Figure 11. Osteoarthritis Therapeutics Report Years Considered

Figure 12. Global Osteoarthritis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Osteoarthritis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Osteoarthritis Therapeutics Market Share by Region: 2024 VS 2031

Figure 15. Global Osteoarthritis Therapeutics Market Share by Players in 2024

Figure 16. Global Top Osteoarthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Therapeutics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Osteoarthritis Therapeutics Revenue in 2024

Figure 18. North America Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Osteoarthritis Therapeutics Market Share by Country (2020-2031)

Figure 20. United States Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Osteoarthritis Therapeutics Market Share by Country (2020-2031)

Figure 24. Germany Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Osteoarthritis Therapeutics Market Share by Region (2020-2031)

Figure 32. China Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Osteoarthritis Therapeutics Market Share by Country (2020-2031)

Figure 40. Mexico Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Osteoarthritis Therapeutics Market Share by Country (2020-2031)

Figure 44. Turkey Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Osteoarthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Pfizer Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 48. Johnson & Johnson Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 49. GlaxoSmithKline Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 50. Bayer Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 51. Eli Lilly Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 52. Novartis Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 54. Horizon Pharma Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 55. Abbott Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 56. Mylan Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 57. Daiichi Sankyo Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 58. TEVA Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 59. Almatica Pharma Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 60. Astellas Pharma Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 61. Tide Pharmaceutical Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 62. Iroko Pharmaceuticals Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 63. Hengrui Pharmaceutical Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 64. Abiogen Pharma Revenue Growth Rate in Osteoarthritis Therapeutics Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Osteoarthritis Drugs Market

Global Drugs for Osteoarthritis Pain Market Insights Forecast to 2030

Global Osteoarthritis Pain Drugs Market Insights Forecast to 2030

Osteoarthritis Pain Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Osteoarthritis Medications Market

Global Osteoarthritis Pain Solution Market Research Report 2024

Medicine for Osteoarthritis Pain Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Osteoarthritis Pain Market

Osteoarthritis Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Knee Osteoarthritis Treatment Market

Global Osteoarthritis Cell Therapy Market Research Report 2024

Hip Osteoarthritis Pain Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hip Osteoarthritis Pain Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Joint Disease Therapeutics Market Research Report 2024

Spine Osteoarthritis Pain Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Orthopedic Therapeutic Hyaluronic Acid End Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Spine Osteoarthritis Pain Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Pain Therapy Solutions for Joints Market Research Report 2024

Global Osteoarthritis Chondrocyte Therapy Market Research Report 2024

Global Regenerative Medicine for Cartilage Market Size Status and Forecast 2021 2027

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions